Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Bexagliflozin in Type 2 Diabetes Mellitus
NCT01377844Phase 2Completed
- Sponsor
- Theracos, Inc.
- Start
- Dec 2011
- Primary completion
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bexagliflozin in type 2 diabetes mellitus (T2DM), sponsored by Theracos, Inc.. Started Dec 2011; status: completed.
02
Drugs
bexagliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01377844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01377844.